Pokhrel Arun, Hakulinen Timo
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Pieni Roobertinkatu 9, FI-00130 Helsinki, Finland.
Eur J Cancer. 2009 Mar;45(4):642-7. doi: 10.1016/j.ejca.2008.10.034. Epub 2008 Dec 8.
A recent method of age-standardisation of relative survival ratios for cancer patients does not require calculation of age-specific relative survival ratios, as ratios of age-specific proportions between the standard population and study group at the beginning of the follow-up are used to substitute the original individual observations. This method, however, leads to direct age-standardisation with weights that are different for each patient group if the general population mortality patterns for the groups are different. This is the case in international comparisons, and in comparisons between genders and time periods. The magnitude of the bias caused by the differences in general population mortality is investigated for comparisons involving European countries and the USA. Patients in each country are assumed to have exactly the same age-specific relative survival ratios as those diagnosed in Finland in 1985-2004. An application of a properly functioning age-standardisation method should then give exactly equal age-standardised relative survival ratios for each country. However, the recent method shows substantial differences between countries, with highest relative survival for populations, where the general population mortality in the oldest ages is the highest. This source of error can thus be a serious limitation for the use of the method, and other methods that are available should then be employed.
一种用于癌症患者相对生存率年龄标准化的最新方法不需要计算特定年龄的相对生存率,因为随访开始时标准人群与研究组之间特定年龄比例的比值被用来替代原始个体观察值。然而,如果各患者组的总体人群死亡率模式不同,该方法会导致直接年龄标准化,且各患者组的权重不同。国际比较、性别比较以及不同时间段的比较中就是这种情况。在涉及欧洲国家和美国的比较中,研究了总体人群死亡率差异所导致的偏差程度。假设每个国家的患者具有与1985 - 2004年在芬兰诊断出的患者完全相同的特定年龄相对生存率。那么,应用一种正常运行的年龄标准化方法应该会使每个国家的年龄标准化相对生存率完全相等。然而,最新方法显示各国之间存在显著差异,在老年人群总体死亡率最高的人群中相对生存率最高。因此,这种误差来源可能是该方法使用的一个严重限制,届时应采用其他可用方法。